Sprint Bioscience AB (publ) (STO:SPRINT)
Sweden
· Delayed Price · Currency is SEK 3.140
+0.030 (0.96%)
Apr 28, 2026, 5:24 PM CET
Sprint Bioscience AB Revenue
In the year 2025, Sprint Bioscience AB had annual revenue of 167.39M SEK with 153.07% growth. Sprint Bioscience AB had revenue of 134.13M in the quarter ending December 31, 2025, with 699.94% growth.
Revenue
167.39M
Revenue Growth
+153.07%
P/S Ratio
1.98
Revenue / Employee
5.58M
Employees
30
Market Cap
331.32M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 167.39M | 101.24M | 153.07% |
| Dec 31, 2024 | 66.14M | 14.46M | 27.97% |
| Dec 31, 2023 | 51.69M | 51.60M | 62,171.08% |
| Dec 31, 2022 | 83.00K | -34.95M | -99.76% |
| Dec 31, 2021 | 35.03M | 15.83M | 82.49% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Bio-Works Technologies AB | 63.11M |
| Mendus AB | -1.44M |
| Xintela AB | 2.28M |
| Corline Biomedical AB | 8.59M |
| Intervacc AB | 20.09M |
| Xbrane Biopharma AB | 152.35M |
| Oncopeptides AB | 71.12M |
Sprint Bioscience AB News
- 5 months ago - Sprint Bioscience AB Transcript: Life Science Summit 2025 - Transcripts